Search Results - "Jurcic, Christina"

Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities by Pohl, Laura, Friedhoff, Jana, Jurcic, Christina, Teroerde, Miriam, Schindler, Isabella, Strepi, Konstantina, Schneider, Felix, Kaczorowski, Adam, Hohenfellner, Markus, Duensing, Anette, Duensing, Stefan

“…Renal cell carcinoma (RCC) is among the most lethal urological malignancies once metastatic. The introduction of immune checkpoint inhibitors has…”
Get full text

La recepción del norte en la literatura en lengua alemana: revisión histórico-literaria de un concepto espacial by Jurcic, Christina

“…The Reception of the North in Literature in German: A Historic and Literary Revision of a Spatial Concept ABSTRACT The influence of Cultural Studies has…”
Get full text

BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study by Friedhoff, Jana, Schneider, Felix, Jurcic, Christina, Endris, Volker, Kirchner, Martina, Sun, Angela, Bolnavu, Iulia, Pohl, Laura, Teroerde, Miriam, Kippenberger, Maximilian, Schwab, Constantin, Kaczorowski, Adam, Zschäbitz, Stefanie, Jäger, Dirk, Hohenfellner, Markus, Stenzinger, Albrecht, Duensing, Anette, Duensing, Stefan

“…Clear cell renal cell carcinoma (ccRCC) is an immunologically vulnerable tumor entity, and immune checkpoint inhibitors are now widely used to treat patients…”
Get full text

Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma by Schneider, Felix, Kaczorowski, Adam, Jurcic, Christina, Kirchner, Martina, Schwab, Constantin, Schütz, Viktoria, Görtz, Magdalena, Zschäbitz, Stefanie, Jäger, Dirk, Stenzinger, Albrecht, Hohenfellner, Markus, Duensing, Stefan, Duensing, Anette

“…Clear cell renal cell carcinoma (ccRCC) is characterized by a high degree of intratumoral heterogeneity (ITH). Besides genomic ITH, there is considerable…”
Get full text

Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer by Nientiedt, Cathleen, Budczies, Jan, Endris, Volker, Kirchner, Martina, Schwab, Constantin, Jurcic, Christina, Behnisch, Rouven, Hoveida, Shirin, Lantwin, Philippa, Kaczorowski, Adam, Geisler, Christine, Dieffenbacher, Svenja, Falkenbach, Fabian, Franke, Desiree, Görtz, Magdalena, Heller, Martina, Himmelsbach, Ruth, Pecqueux, Carine, Rath, Mathias, Reimold, Philipp, Schütz, Viktoria, Simunovic, Iva, Walter, Elena, Hofer, Luisa, Gasch, Claudia, Schönberg, Gita, Pursche, Lars, Hatiboglu, Gencay, Nyarangi-Dix, Joanne, Sültmann, Holger, Zschäbitz, Stefanie, Koerber, Stefan A., Jäger, Dirk, Debus, Jürgen, Duensing, Anette, Schirmacher, Peter, Hohenfellner, Markus, Stenzinger, Albrecht, Duensing, Stefan

“…•We show that a substantial proportion of patients undergoing RPX for localized high-risk or locally advanced prostate cancer harbor mutations in DNA damage…”
Get full text